Impact of time to initiation of postoperative radiotherapy after neoadjuvant chemotherapy on the prognosis of breast cancer: A retrospective cohort study in China.

Xie, Yuxin; Zhang, Yingjie; Xie, Keqi; Zhong, Xiaorong; Zheng, Hong; Gou, Qiheng

Xie, Yuxin; Zhang, Yingjie; Xie, Keqi; Zhong, Xiaorong; Zheng, Hong; Gou, Qiheng.

Afiliação

Xie Y; Department of Medical Oncology of Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Zhang Y; Laboratory of Molecular Diagnosis of Cancer, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xie K; Department of Radiation Therapy, West China Hospital, Sichuan University, Chengdu, China.
Zhong X; Department of Anesthesiology, Mianyang Central Hospital, Mianyang, Sichuan, China.
Zheng H; Department of Medical Oncology of Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Gou Q; Laboratory of Molecular Diagnosis of Cancer, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Int J Cancer ; 151(5): 730-738, 2022 09 01.

Article em En | MEDLINE | ID: mdl-35333401

Assuntos

Neoplasias da Mama; Terapia Neoadjuvante; Neoplasias da Mama/tratamento farmacológico; Neoplasias da Mama/cirurgia; Quimioterapia Adjuvante; Estudos de Coortes; Feminino; Humanos; Prognóstico; Estudos Retrospectivos

Palavras-chave

breast cancer; mortality risk; neoadjuvant chemotherapy; prognosis; time to radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google